MiniMed posts double-digit sales growth, widening net loss [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
By the numbers FY26 Q3 revenue: $790 million 15% increase year over year Net loss: $119 million Compared with a net loss of $10 million in Q3 2025 MiniMed, Medtronic's diabetes spinoff, posted financial results on Friday showing double-digit revenue growth and a widening net loss. MiniMed reported revenue of $790 million, a 15% increase year over year, for its fiscal third quarter, which ended in January. However, the company also reported a net loss of $119 million for the quarter, compared with a net loss of $10 million in the year-ago period. The results predate MiniMed's initial public offering in March. MiniMed kept about $309 million in proceeds from the IPO, according to the filing. BTIG analyst Marie Thibault wrote in a research note that MiniMed's revenue growth has been driven by sales of its latest automated insulin delivery system. The company is poised for continued growth with its Simplera Sync continuous glucose monitor, which received Food and Drug Adm
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (ABT) had its price target lowered by UBS Group AG from $158.00 to $135.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Argus from $140.00 to $125.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Leerink Partners from $119.00 to $106.00. They now have a "market perform" rating on the stock.MarketBeat
- Abbott Laboratories: Buy The Dip On This Dividend King [Seeking Alpha]Seeking Alpha
- Abbott's CancerGuard Progress Adds New Dimension To Diagnostics Growth Story [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website